Mosaic ImmunoEngineering Inc. (CPMV) › Shareholders' EquityMosaic ImmunoEngineering Inc. (CPMV) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $23.35M2011: $12.02M2012: $7.09M2013: $8.14M2014: $6.51M2015: $5.02M2016: $3.75M2017: $3.70M2018: $2.50M2019: $1.70M2020: -$422.5K2021: -$2.80M2022: -$4.88M2023: -$5.87M2024: -$6.79M2025: -$7.48M-$7.48M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$7.48M-10.1%2024-$6.79M-15.6%2023-$5.87M-20.2%2022-$4.88M-74.5%2021-$2.80M-562.4%2020-$422.5K-124.9%2019$1.70M-32.0%2018$2.50M-32.6%2017$3.70M-1.2%2016$3.75M-25.2%2015$5.02M-23.0%2014$6.51M-20.0%2013$8.14M+14.8%2012$7.09M-41.0%2011$12.02M-48.5%2010$23.35M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share